Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04988217Phase 1/2Completed
Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
Coronavirus Disease 2019
PrincipalinvestigatorStart date: 2021-09-15

Research Network

Collaboration Network

16 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Pontificia Universidad Catolica de Chile

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04988217Phase 1/2PrincipalInvestigator

Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)

Coronavirus Disease 2019
Completed

All 1 trials loaded